Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
309M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
139M
-
Shares change
-
+6.4M
-
Total reported value, excl. options
-
$1.35B
-
Value change
-
+$34.3M
-
Put/Call ratio
-
0.37
-
Number of buys
-
86
-
Number of sells
-
-67
-
Price
-
$9.70
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q4 2015
186 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share as of Q4 2015.
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 139M shares
of 309M outstanding shares and own 44.92% of the company stock.
Largest 10 shareholders include FMR LLC (18.7M shares), PERCEPTIVE ADVISORS LLC (15.2M shares), Redmile Group, LLC (10.3M shares), Sectoral Asset Management Inc (7.97M shares), VANGUARD GROUP INC (6.23M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.93M shares), BlackRock Fund Advisors (5.36M shares), STATE STREET CORP (5.16M shares), JANUS CAPITAL MANAGEMENT LLC (5.09M shares), and JENNISON ASSOCIATES LLC (4.12M shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.